Cytomel (Liothyronine) Cost in Wyoming 2026

What Does Liothyronine Actually Cost in Wyoming?

Generic liothyronine tablets cost an average of $35 per month cash-pay across Wyoming retail pharmacies in 2026, making it one of the more affordable thyroid medications when purchased without insurance. Brand-name Cytomel (Pfizer) carries a manufacturer list price of $120 per month, though virtually no cash-pay patient needs to pay that figure given the wide availability of generics and discount programs.

Liothyronine is the synthetic form of triiodothyronine (T3), the more metabolically active thyroid hormone [1]. It is FDA-approved for hypothyroidism, thyroid suppression therapy, and myxedema coma [2]. Clinicians sometimes add it to levothyroxine (T4) monotherapy when patients remain symptomatic despite adequate T4 dosing, a practice supported by the landmark Bunevicius et al. Trial published in the New England Journal of Medicine, which found that a T4/T3 combination improved mood and neuropsychological function compared with T4 alone in 33 patients over 5 weeks [3].

Pricing at Wyoming pharmacies varies by chain versus independent pharmacy, tablet strength, and whether the patient uses a discount card. The 5 mcg tablet tends to cost slightly less per unit than the 25 mcg tablet when normalized to dose, so patients taking higher doses can sometimes save by requesting a larger-strength tablet and splitting it, pending physician approval. Doses of 25 mcg to 75 mcg daily are typical for hypothyroidism adjunct use, though the exact dose is individualized [2].

Cash prices fluctuate quarter to quarter. A 30-day supply of generic liothyronine 25 mcg once daily averaged $35 at Wyoming retail locations as of early 2026. That figure can drop below $20 at some locations when a discount coupon is applied.

Wyoming Medicaid Coverage for Liothyronine

Wyoming Medicaid does not cover Cytomel or generic liothyronine as an adjunct treatment for hypothyroidism. Patients enrolled in Wyoming Medicaid (WY Medicaid Equality Care) should expect no benefit for liothyronine prescriptions written for thyroid hormone supplementation and will need to pay out of pocket or seek an alternative coverage mechanism [4].

This exclusion is not unique to Wyoming. Many state Medicaid programs limit thyroid hormone reimbursement to levothyroxine monotherapy because clinical practice guidelines from the American Thyroid Association have historically recommended T4 monotherapy as first-line, reserving T3-containing regimens for select patients [5]. The ATA's 2014 guidelines state that "levothyroxine should remain the standard of care for hypothyroidism" while acknowledging individual variation in thyroid hormone metabolism [5].

Patients on Wyoming Medicaid who genuinely cannot tolerate levothyroxine alone may ask their prescriber to submit a prior authorization documenting clinical necessity. Prior authorization approval for non-preferred agents is rare on Wyoming Medicaid but not impossible, particularly when documented lab evidence and symptom burden support the request.

Medicare Part D plans operating in Wyoming handle liothyronine differently from Medicaid. Coverage depends on the specific Part D plan's formulary. Some plans place generic liothyronine on Tier 1 or Tier 2, producing a copay under $10 per month. Wyoming residents enrolled in Medicare Advantage should request a formulary exception letter from their prescriber if liothyronine is not on the plan's standard formulary [6].

Is Compounded Liothyronine Legal in Wyoming?

Compounded liothyronine T3 is legal in Wyoming when prepared by a 503A-licensed pharmacy operating under a valid patient-specific prescription. Wyoming follows federal USP guidelines and the Drug Quality and Security Act (DQSA) of 2013 for compounded preparations [7].

503A pharmacies compound medications for individual patients based on a licensed prescriber's order. They differ from 503B outsourcing facilities, which produce larger batches for hospitals. In Wyoming, a prescriber can send a patient's liothyronine compound prescription to any licensed 503A pharmacy registered with the Wyoming State Board of Pharmacy [8]. The compound typically arrives as a capsule or tablet in a specific microgram dose that may not be available commercially, such as 7.5 mcg or 12.5 mcg, giving prescribers more precise titration options.

Compounded liothyronine runs approximately $40 per month in Wyoming as of 2026. That is slightly more than the generic retail cash price but may offer dosing flexibility that justifies the modest premium. The FDA does not test or pre-approve compounded formulations, and bioavailability can differ from FDA-approved tablets [9]. A 2013 FDA guidance document notes that compounded drugs lack the manufacturing oversight of commercially approved products, meaning potency and release characteristics may vary between batches [9].

Sustained-release (SR) compounded liothyronine is available from some 503A pharmacies. The evidence on whether SR formulations provide clinical benefit over immediate-release tablets is mixed. A randomized trial by Hoang et al. (N=70) found that patients on SR compounded T3 had better quality-of-life scores than those on immediate-release T3, though thyroid hormone levels were similar [10]. Prescribers and patients should weigh that data against the lack of FDA oversight before choosing SR compounds.

How Private Insurance Handles Liothyronine in Wyoming

Wyoming commercial insurance plans through the ACA marketplace and employer-sponsored coverage handle liothyronine variably. Generic liothyronine appears on many Tier 1 formularies, producing a $0 to $15 copay per month after deductible. Brand-name Cytomel, however, often sits on Tier 3 or Tier 4, leading to copays of $40 to $100 per month or higher before meeting an annual out-of-pocket maximum.

Patients with Wyoming commercial plans should take three practical steps. First, ask the prescriber to write the prescription as "liothyronine (generic acceptable)" so the pharmacy can substitute the lower-tier generic automatically. Second, check the specific plan's drug formulary on HealthCare.gov or the insurer's portal before filling the prescription. Third, if the plan has a deductible phase, compare the insurance "discounted" price with a GoodRx or similar coupon price, because discount coupons sometimes beat the insured price before deductible [11].

The ACA requires that plans cover FDA-approved prescription drugs without lifetime limits, but formulary placement and tier assignment remain at the insurer's discretion as long as the plan meets minimum essential coverage standards [12]. Wyoming has no state mandate requiring liothyronine formulary placement.

Pfizer Savings Programs and Generic Manufacturer Cards

Pfizer offers a savings card for brand-name Cytomel that can reduce the cost to as low as $0 to $25 per month for commercially insured patients who qualify. The card is not valid for patients on Medicaid, Medicare, or other federal or state government-funded programs [13]. Eligible Wyoming patients can enroll at the Pfizer program website and present the card at any participating Wyoming pharmacy.

Generic liothyronine manufacturers including Mayne Pharma and Lannett Company also occasionally offer patient assistance or savings cards, though availability changes quarterly. Patients should search the specific manufacturer's website printed on their prescription bottle to find current offers.

For uninsured or underinsured Wyoming residents, the NeedyMeds database and the Partnership for Prescription Assistance list income-based programs that may supply liothyronine at reduced or no cost [14]. These programs require documentation of income and a prescriber's letter confirming diagnosis.

Telehealth Prescribing of Liothyronine in Wyoming

Telehealth prescribing of liothyronine is legal in Wyoming as of 2026. Wyoming follows federal DEA rules for controlled substances via telehealth, and liothyronine is not a controlled substance, so no in-person visit is required before a telehealth clinician can prescribe it [15]. A Wyoming-licensed prescriber or an out-of-state prescriber holding a Wyoming telehealth registration may write the prescription after a synchronous audio-video consultation.

Wyoming adopted interstate telehealth rules aligned with the Interstate Medical Licensure Compact, which allows physicians licensed in a compact member state to practice telehealth in Wyoming without a separate Wyoming license [15]. Nurse practitioners prescribing liothyronine via telehealth in Wyoming must hold an active Wyoming APRN license or a compact authorization.

From a clinical standpoint, telehealth prescribing of liothyronine requires the same diagnostic workup as in-person care: a confirmed hypothyroidism diagnosis, baseline TSH and free T4 measurements, and documentation of the clinical rationale for adding T3 to a regimen. The American Thyroid Association notes that T3 supplementation should be considered only after levothyroxine has been optimized and persistent symptoms remain [5]. Telehealth providers who prescribe T3 without reviewing prior thyroid labs and prior medication trials are not meeting the standard of care regardless of the medium [5].

The Cheapest Way to Get Liothyronine in Wyoming

The lowest total cost for most uninsured Wyoming patients comes from buying generic liothyronine with a free GoodRx or similar discount coupon at a high-volume chain pharmacy. Prices below $20 per month for a standard 25 mcg daily dose are achievable at Walmart, Costco, and some independent pharmacies in Cheyenne, Casper, and Laramie [16].

Four concrete steps for minimizing cost:

1. Ask the prescriber for generic liothyronine, not brand-name Cytomel. Generics are therapeutically equivalent per FDA standards [17].
2. Compare coupon prices across pharmacy chains using GoodRx, RxSaver, or the pharmacy's own app before submitting the prescription.
3. Ask for a 90-day supply rather than 30 days. Many pharmacies dispense a 90-day supply at a price below three times the monthly price, saving 10 to 20 percent.
4. If your dose requires a strength not commercially available, ask the prescriber whether a 503A compound at the $40/month price point makes clinical sense.

Patients switching from levothyroxine monotherapy to a T4/T3 combination should have TSH, free T4, and free T3 measured 6 to 8 weeks after any dose change, per standard endocrinology practice [5]. Keeping labs current also ensures any prior authorization request to insurance includes up-to-date clinical documentation.

Clinical Pharmacology: Why T3 Dosing Precision Matters for Cost

Liothyronine has a short plasma half-life of approximately 1 to 2 days, compared with levothyroxine's 7-day half-life [1]. That short half-life means missed doses produce faster symptom recurrence and that twice-daily dosing often provides more stable T3 levels than once-daily dosing. Bunevicius et al. Demonstrated that substituting 12.5 mcg of T3 for 50 mcg of T4 in the daily regimen improved multiple quality-of-life measures without adverse cardiovascular effects over 5 weeks of follow-up [3].

More recent data from Idrees et al. (2021, N=65) confirmed that free T3 levels varied significantly throughout the day in patients on once-daily liothyronine, with peak levels 2 to 4 hours post-dose and trough levels near the lower reference limit before the next dose [18]. That pharmacokinetic pattern is relevant to cost because patients experiencing symptom recurrence at trough may escalate doses unnecessarily, increasing monthly cost. Splitting the daily dose into two equal administrations morning and midday can reduce peak-to-trough swings without increasing total daily dose or total monthly cost [18].

Dose requirements range from 5 mcg to 75 mcg per day for adjunct hypothyroid management, with most patients stabilizing between 12.5 mcg and 25 mcg added to their existing levothyroxine regimen [2]. Patients requiring only 5 mcg to 12.5 mcg daily may find that splitting a 25 mcg tablet cuts the monthly drug cost to under $20.

Wyoming-Specific Pharmacy Field

Wyoming has 23 counties, several with limited pharmacy access. Teton, Natrona, and Laramie counties have the densest pharmacy options and the most competitive generic liothyronine pricing. Rural counties such as Niobrara, Weston, and Goshen may have a single retail pharmacy, limiting price competition and coupon applicability.

Mail-order pharmacy is a practical alternative for Wyoming residents in rural counties. Both Express Scripts and CVS Caremark mail-order services ship to Wyoming addresses, and a 90-day supply of generic liothyronine via mail order through an insured plan typically runs $0 to $30 after formulary copay [19]. Uninsured patients can use Costco's mail-pharmacy program, which does not require a Costco membership for prescription orders and lists liothyronine prices online.

The Wyoming Board of Pharmacy maintains a list of licensed in-state and out-of-state pharmacies permitted to dispense to Wyoming residents [8]. Patients ordering from online pharmacies should verify licensure through that board to avoid counterfeit or subpotent thyroid medications. The FDA's BeSafeRx program provides a tool for checking online pharmacy legitimacy [20].

Safety Monitoring Costs to Factor In

The true monthly cost of liothyronine therapy is not just the drug price. It includes thyroid function testing, which a prescriber should order every 6 to 8 weeks during dose titration and every 6 to 12 months once stable [5]. A TSH plus free T4 panel at a Wyoming Quest Diagnostics or LabCorp draw site costs $30 to $80 cash-pay without insurance. Adding free T3 to the panel adds $15 to $40.

Cardiac monitoring deserves attention because supratherapeutic T3 levels can precipitate atrial fibrillation and worsen angina. The American Heart Association notes that hyperthyroidism, whether endogenous or exogenous, is an independent risk factor for atrial fibrillation [21]. Patients over 65 or with known cardiac disease should have an electrocardiogram at baseline and at least annually while on T3-containing regimens. An EKG at a Wyoming outpatient clinic runs $50 to $150 without insurance.

Factoring in labs and monitoring, the true cost of well-managed liothyronine therapy in Wyoming runs $50 to $120 per month when labs are annualized, not the $35 drug price alone.

What Clinicians at HealthRX Assess Before Prescribing Liothyronine in Wyoming

HealthRX clinicians follow a structured review before recommending liothyronine to a Wyoming patient. The checklist includes: confirmed primary hypothyroidism diagnosis with TSH above the reference range on at least two separate draws; optimized levothyroxine dose with persistent free T4 in the upper half of the reference range; free T3 below mid-range despite adequate T4; documented residual symptoms such as fatigue, cold intolerance, or cognitive difficulty; absence of uncontrolled cardiac arrhythmia; and no recent myocardial infarction within the preceding 6 months [2].

Patients who meet all criteria may be candidates for a trial of combination therapy. The starting dose at HealthRX is typically 5 mcg of liothyronine added to the existing levothyroxine, with levothyroxine reduced by 25 mcg to 50 mcg simultaneously to maintain approximate total thyroid hormone equivalence. That conservative titration mirrors the protocol used in Bunevicius et al. And minimizes the risk of transient hyperthyroid symptoms [3].

A repeat TSH, free T4, and free T3 panel is ordered at 6 weeks. If TSH remains above 1.0 mIU/L and free T3 is below mid-range, the liothyronine dose may increase by 5 mcg. This stepwise approach limits unnecessary dose escalation, which in turn limits monthly drug cost.